Virology testing consist of diagnostic methods that help in early detection of the disease such as hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated disease. Virology testing examines for detection of viral antigens, nucleic acids, and antibodies in the given sample in order to confirm the presence of particular viral infection. There are more than 100 viral diseases identified.

New advanced molecular based virology testing methods has been evolved in recent past such as immunoassay, nucleic acid based amplification testing methods (PCR based methods), mass spectrometry based detection methods and next generation genome sequencing methods, which are accurate, quick, and provides result for diversified viral infections.

Virology Testing Market- Market Dynamics
Virology testing market is projected to witness significant growth during forecast period with rising prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs, Ebola, Influenza based viral infections, severe acute respiratory syndrome from coronavirus, hemorrhagic fever etc. across world. Early and fast diagnosis of virus infection is very essential to start treatment course.

According to the World Health Organization (WHO), January 2018 factsheet, all types of influenza in combination causes annual epidemics about 3 to 5 million cases with severe stage of illness, which results in the  290 000 to 650 000 deaths worldwide annually. Although rapid diagnostic tests are majorly used, PCR based techniques are being adopted for detection of influenza.

Furthermore, advances in anti-viral therapy in terms of detection techniques, medication, and vaccines are expected to drive the virology testing market growth. Worldwide efforts are going on to find novel vaccines and novel medication for treating viral resistant diseases. For instance, Pritelivir is investigational drug for herpes simplex virus (HSV) by AiCuris has proven to be very effective as compared to the current standard antiviral treatments for genital herpes in Phase II trials. Extensive research has been conducted worldwide for treatment of high epidemic viral disease such as Ebola, Dengue, and Malaria.

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/2037

Advancement in diagnostic technologies from culture based methods to nucleic acid and molecular diagnosis techniques is leading to new product launches by key players, which is expected to drive growth of virology testing market. For instance, Roche in 2017, launched cobas HPV Assay to be performed on the cobas 6800/8800 Systems. Cobas HPV assay aids in identifying women at risk of cervical cancer, performed on cobas 6800/8800 Systems which is fully automated system with capacity to deliver large diagnostic services.

Virology Testing Market - Regional Insights
On the basis of Geography, virology testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is projected to dominate the virology testing market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), around 5,251 deaths were reported due to influenza infection in 2015.

According to the National Ambulatory Medical Care Survey: 2015 data findings, around 16.8 million people visit to physician for treatment of infectious and parasitic diseases in U.S. Moreover, according to a study from the Society for Risk Analysis, 2016, GDP loss of a viral pandemic outbreak in the U.S. was recorded between US$ 34.4 billion and US$ 45.3 billion in 2015.

Furthermore, robust healthcare infrastructure and highest healthcare spending in world makes the U.S. most lucrative market. However, Asia Pacific is expected to witness high CAGR due to outbreak of viral influenza and largest patient pool infected with HIV.

Virology Testing Market - Competitive Landscape
Some of the key players operating in the virology testing market include F. Hoffmann-La Roche AG.Bio-Rad Laboratories Inc. , Hologic Inc., Abbot Healthcare, Fujirebio Diagnostics Inc., Thermo Fisher Scientific Inc., Cepheid, bioMerieux SA, Qiagen, Diasorin, Scienion AG, Siemens AG Grifols, Eiken Chemical Co Ltd., Sequenom, and Diamedix Inc.

Virology Testing Market - Market Taxonomy
Instruments,Assay kits and consumables,On the basis of end user, the global virology testing market is segmented into:,Hospitals,Diagnostic Centers,Blood Banks,Others,On the basis of region, the global virology testing market is segmented into:,North America,Latin America,Europe,Asia Pacific,Middle East,Africa

Click To Read More On Virology Testing Market
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]